Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol prolonged-release 250 mg pharmacokinetics study in healthy adults
NL-OMON32556Active, not recruiting
- Sponsor
- Janssen Pharmaceutical
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tapentadol in acute pain and chronic pain, sponsored by Janssen Pharmaceutical. Primary endpoint: Pharmacokinetics after single and multiple doses of tapentadol. Started Sep 2008; status: active, not recruiting.
02
Drugs
tapentadol
03
Conditions
acute painchronic pain
Beyond the preview
Go deeper on NL-OMON32556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON32556.